LP-003 Dose 1 (Single)

BIOLOGICAL2 trials

Sponsors

Longbio Pharma

Conditions

Allergic DiseasesChronic Spontaneous Urticaria

Phase 1

A Study of Single and Multiple Doses of LP-003 in Healthy Adult Participants

CompletedNCT06294288

Longbio PharmaChronic Spontaneous Urticaria

Start: 2022-07-13End: 2024-03-04Updated: 2025-12-12

A Study of Single Dose of LP-003 in Adolescent Subjects

Active, not recruitingNCT07148557

Longbio PharmaAllergic Diseases

Start: 2025-10-01End: 2026-09-30Updated: 2026-02-17